Jiangzhong Pharmaceutical

Jiangzhong Pharmaceutical is a company listed under the stock ticker 600750 (CN).

View the org chart displaying its 12 main executives

Most searched biographies at Jiangzhong Pharmaceutical

• Weiquan Liu, Acting Chairman of the Board
• Lianjin Hong, Independent Director
• Weidong Zhang, Independent Director

Create your alert
to follow the executive moves at Jiangzhong Pharmaceutical.

Jiangzhong Pharmaceutical has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Jiangzhong Pharmaceutical

Social media about Jiangzhong Pharmaceutical

• Jiangzhong Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Jiangzhong Pharmaceutical on LinkedIn, Twitter & YouTube

Call Jiangzhong Pharmaceutical at +86 791 ...

View the org chart

Register to receive your alert

Report an error